Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Genetic counselling

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	343	1192
Performance Status recorded	96%	93%
PSA completed	78%	78%
Gleason Score completed	84%	80%
TNM completed	80%	85%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	1166	39897
Percentage of men diagnosed with metastatic disease	20%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	103	4684
Percentage of men with low-risk localised disease receiving radical treatment	12%	8%
No. of men diagnosed with locally advanced disease	538	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	66%	68%

	Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023)	100
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	12%
No. of men who received radical prostatectomy (September 2020 - August 2021)	95
Adjusted percentage of men experiencing at least one GU complication (%)	13%
No. of men who received radical radiotherapy (September 2020 - August 2021)	333
Adjusted percentage of men experiencing at least one GI complication (%)	10%